bioMérieux S.A. (BMXMF)

Cost of Revenue

€3.71B

TTM · Period ending: · EUR

BMXMF logo

BMXMF Cost of Revenue

Latest reported€3.71B EUR
BMXMF Cost of Revenue · EUR (€473.20M → €3.71B)
High-resolution chart · PNG

BMXMF cost of revenue history

Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. Cost of Revenue — Annual fiscal periods (EUR)
Period endingCost of Revenue (EUR)
1,761,000,000
1,764,600,000
1,617,400,000
1,580,400,000
1,412,500,000
1,364,500,000
1,208,200,000
1,119,100,000
1,076,400,000
1,002,500,000
975,400,000
853,900,000
763,300,000
755,600,000
666,100,000
634,900,000
563,800,000
517,500,000
497,000,000
495,000,000
473,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.